首页> 外文期刊>Urologic oncology >Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study
【24h】

Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study

机译:使用选定的尿液DNA甲基化生物标志物检测尿路上癌,上部尿路上皮癌,膀胱尿路癌,膀胱癌和尿路上皮癌:一种预期,单中心研究

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Hematuria is the most common symptom of urothelial carcinomas (UC) but is often idiopathic. Cystoscopy is expensive which involves considerable patient discomfort, and conventional urine cytology for noninvasive UC detection and disease monitoring suffers from poor sensitivity. We aim to evaluate the performance of genes selected from a previous study in detecting UC, especially among patients with gross hematuria, as well as upper tract urothelial carcinoma (UTUC) and bladder carcinoma separately, in voided urine samples.
机译:简介:血尿是尿路上皮癌(UC)最常见的症状,但往往是特发性的。 膀胱镜检查是昂贵的,这涉及相当大的患者的不适,常规尿液细胞学对于非侵入性UC检测和疾病监测的敏感性较差。 我们的目标是评估从先前研究中选择的基因的表现,特别是在血尿总血尿的患者中,以及上部尿液样品中的上部尿液尿癌(UTUC)和膀胱癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号